America’s Scary New Reality: The Poor Can’t Afford Pneumonia Treatment Anymore
And guess who's behind this disastrous shift?
According to a family physician writing at Daily Kos, what was once a life-saving $4 antibiotic now costs more than 10 times the price thanks to corporate greed and none other than the Koch brothers. In other words, slowly but surely, only the rich will be able to afford survival in the good ol’ USA.
Daily Kos:
For years, doxycycline has been a valuable drug for physicians who treat the indigent — unemployed or underemployed folks without insurance. A staple of $4 drug lists, it can be used to treat everything from bronchitis to “walking” pneumonia to urinary tract infections to skin infections to acne to venereal disease—and it covers some rarer infections like Lyme’s and is sometimes used for malaria prevention, too.
For as long as I can remember–and I am pretty damn old—doxycycline, a twice a day form of tetracycline has been widely available and cheap as dirt.
And then, this winter, something surprising and very troubling happened….
—Posted by Natasha Hakimi Zapata
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Editorial Cartoons
Author Interview
After decades of shaping national narratives, corporate America has weaponized its playbook in a more aggressive way, the authors of Corporate Bullsh*t warn.
Courts & Law
A little-noticed 9-0 decision points ominously toward a post-parody culture.
With Donald Trump or Joe Biden, the oligarchs win and we lose, which is why the next few weeks will be devoted to destroying Bernie Sanders.
So-called “McTeacher’s Nights” rip off teachers, schools, and McDonald’s workers under the guise of raising funds.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.